Enrolling by invitationEarly Phase 1NCT07472023

Regenerative Medicine and Stem Cell-Based Interventions for Inner Ear Trauma, Tinnitus, and Sensorineural Hearing Loss

Studying Sudden sensorineural hearing loss

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Truway Health, Inc.
Principal Investigator
Gavin C Solomon, CEO
Truway Health, Inc.
Intervention
Audiologic Monitoring(other)
Enrollment
120 target
Eligibility
All sexes
Timeline
20262099

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07472023 on ClinicalTrials.gov

Other trials for Sudden sensorineural hearing loss

Additional recruiting or active studies for the same condition.

See all trials for Sudden sensorineural hearing loss

← Back to all trials